IL24

Across TCGA pan-cancer cohorts, IL24 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IL24 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher IL24 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated IL24 expression acts as an unfavorable survival marker.

OV and UCEC are the cancer types where IL24 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	All	0.165	0.541	.004	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IL24–OV (DFS)

Open the OV breakdown →